TP53 and colorectal neoplasm: Study of clinical samples showed that ASPP2 was highly expressed in normal tissues adjacent to colorectal tumours, suggesting that low levels of ASPP2 in colorectal tumours might have contributed to the tumour survival in both p53-dependent and -independent manners following chemotherapy.